MHTP Clinical Trials

Since opening in December 2015, the Monash Health Translation Precinct (MHTP),(link is external) a collaborative initiative of Monash Health, School of Clinical Sciences at Monash Health, Monash University and Hudson Institute of Medical Research(link is external), has proudly facilitated more than 200 clinical trials within the state-of-the-art MHTP Clinical Trials Centre. In an Australian first, our unique facility supports research conducted at Monash University and the Hudson Institute of Medical Research in collaboration with Monash Health, the largest public health service in Victoria.

Our dedicated and self-contained clinical research and trials facility has revolutionised how trials are conducted within Monash Health.  Our co-location with researchers, on level 3 of the purpose-built Translational Research Facility, at the precinct, enhances collaboration and links between basic and clinical research and patient care, expediting translation of vital discoveries to the bedside.

The MHTP Clinical Trials Centre, directly connected to Monash Medical Centre by a link bridge, contains 10 consulting rooms, 8 clinical beds and 21 treatment chairs dedicated to clinical trials patients and can be accessed 24/7 should a trial require. Dedicated research nurses provide timely and accurate protocol-required data in a professional, warm and inviting environment.

Multiple Monash Health departments access the Clinical Trials Centre including Haematology, Oncology, Gastroenterology, Lung and Sleep, Diabetes, Infectious Diseases, Neurology, Stroke, Nephrology, Critical Care and ENT.  Our trials are helping patients with a range of diseases and conditions, including lymphoma, advanced solid tumours, hepatitis, cystic fibrosis and asthma.

As well as our dedicated Clinical Trials Centre at the MHTP, we also offer a large number of food, nutrition and sleep trials at BASE (Be Active, Sleep, Eat), at our Notting Hill campus.

Participants sought for research studies and clinical trials

Areas of research


Title of studyPosted Recruitment end date Further info and contact
Obicetrapib and Cardiovascular Outcomes: A Placebo-Controlled, Double-Blind, Randomized Phase 3 Study to Evaluate the Effect of 10 mg Obicetrapib in Participants With Atherosclerotic Cardiovascular Disease (ASCVD) Who are Not Adequately Controlled Despite 22 Feb 2023 15 Sep 2023 Miss Nila Khalkhali
03 7511 1258

Women's Health

Title of studyPosted Recruitment end date Further info and contact
Can intrapartum Sildenafil Citrate safely avert the risks of contraction-induced hypoxia in labour? – iSEARCH 12 Jan 2023 31 May 2024 Dr   Holly Giles-Clark
Biomarkers to improve outcomes of complications in pregnancy – BIOCiP 11 Jan 2023 28 Feb 2025 Dr   Yizhen (Amy) Liu
03 9594 6666
A randomised Trial of URsodeoxycholic acid versus RIFampicin in severe early onset Intrahepatic Cholestasis of pregnancy: the TURRIFIC study. 08 Dec 2022 31 Dec 2023 Prof   Ben W. Mol
03 9594 5383
A Randomised Controlled Trial of Antenatal Melatonin Supplementation in Fetal Growth Restriction for Fetal Neuroprotection: The PROTECT Me trial 14 Jul 2021 28 Apr 2023 Ms   Ebony LaPosta
03 9594 5383
Comparing the Effectiveness of Vaginal Progesterone and Cervical Pessary in the Prevention of Preterm Birth in Women with a Twin Pregnancy and a Short Cervix. Quad-P Twins Study 10 Sep 2019 29 Dec 2023 Dr   Claire McGannon
03 9594 5383